| 301/399 | US=8 / Quimioterapia Reed E. Cisplatin, carboplatin, and oxaliplatin. In: Chabner BA, Longo DL. Cancer chemotherapy and biotherapy: principles and practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2006. p. 332-43. ISBN 978-0-7817-5628-6. CISPLATINA; CARBOPLATINA; OXALIPLATINA; FARMACOLOGIA SUBCELULAR; MECANISMOS DE ACAO; AGENTES DE PLATINA; EFEITOS IMUNOLOGICOS; MECANISMOS DE RESISTENCIA; TOXICIDADES DE ORGAOS; FARMACOLOGIA CLINICA |
| 302/399 | US=8 / Quimioterapia Willems EW, Nooter K, Verweij J. Antitumor antibiotics. In: Chabner BA, Longo DL. Cancer chemotherapy and biotherapy: principles and practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2006. p. 359-70. ISBN 978-0-7817-5628-6. ANTIBIOTICOS ANTITUMORAIS; DACTINOMICINA; MECANISMOS DE ACAO; FARMACOLOGIA CELULAR; MECANISMOS DE RESISTENCIA; FARMACOLOGIA CLINICA; TOXICIDADE; MITOMICINA C; ECTEINASCINEDIN-743 |
| 303/399 | US=8 / Quimioterapia Sparreboom A, Zamboni WC. Topoisomerase I-targeting drugs. In: Chabner BA, Longo DL. Cancer chemotherapy and biotherapy: principles and practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2006. p. 371-413. ISBN 978-0-7817-5628-6. TOPOISOMERASE I; DROGAS-ALVO; CAMPTOTECINA; TOPOTECANO; IRINOTECANO |
| 304/399 | US=8 / Quimioterapia Doroshow JH. Anthracyclines and anthracenediones. In: Chabner BA, Longo DL. Cancer chemotherapy and biotherapy: principles and practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2006. p. 414-50. ISBN 978-0-7817-5628-6. ANTRACICLINAS; ANTRACENEDIONAS; DAUNORUBICINA; DAUNOMICINA; DOXORRUBICINA; MITOXANTRONA |
| 305/399 | US=8 / Quimioterapia Pommier Y, Goldwasser F. Topoisomerase II inhibitors: the epipodophyllotoxins, acridines, and ellipticines. In: Chabner BA, Longo DL. Cancer chemotherapy and biotherapy: principles and practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2006. p. 451-75. ISBN 978-0-7817-5628-6. INIBIDORES DA TOPOISOMERASE II; EPIPODOFILOTOXINAS; ACRIDINAS; ELIPTICINAS; FARMACOLOGIA MOLECULAR; FARMACOLOGIA CELULAR; FARMACOLOGIA CLINICA |
| 306/399 | US=8 / Quimioterapia Chabner BA, Friedmann AM. Asparaginase. In: Chabner BA, Longo DL. Cancer chemotherapy and biotherapy: principles and practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2006. p. 476-83. ISBN 978-0-7817-5628-6. ASPARAGINASE; PROPRIEDADES; MECANISMOS DE ACAO; FARMACOLOGIA CELULAR; RESISTENCIA CELULAR; FARMACOLOGIA CLINICA |
| 307/399 | US=8 / Quimioterapia Mrugala MM, Batchelor TT, Supko JG. Delivering anticancer drugs to brain tumors. In: Chabner BA, Longo DL. Cancer chemotherapy and biotherapy: principles and practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2006. p. 484-501. ISBN 978-0-7817-5628-6. DROGAS ANTICANCER; TUMORES CEREBRAIS; BARREIRA SANGUE-CEREBRO; ENTREGA DE DROGAS; INTERACAO MEDICAMENTOSA |
| 308/399 | US=8 / Quimioterapia Roberts Junior TG. Food and drug administration role in oncology product development. In: Chabner BA, Longo DL. Cancer chemotherapy and biotherapy: principles and practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2006. p. 502-15. ISBN 978-0-7817-5628-6. FOOD AND DRUG ADMINISTRATION (FDA); DESENVOLVIMENTO DE PRODUTOS DE ONCOLOGIA |
| 309/399 | US=8 / Quimioterapia Rosovsky RP, Kuter DJ. Central venous catheters: care and complications. In: Chabner BA, Longo DL. Cancer chemotherapy and biotherapy: principles and practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2006. p. 516-28. ISBN 978-0-7817-5628-6. |
| 310/399 | US=8 / Quimioterapia Fourie J, Diasio RB. Pharmacogenetics. In: Chabner BA, Longo DL. Cancer chemotherapy and biotherapy: principles and practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2006. p. 529-48. ISBN 978-0-7817-5628-6. |
| 311/399 | US=8 / Quimioterapia Colevas AD, Scharf O, Vereshchagina LA, Dancey JE, Ivy SP, Neckers L, Kaufman B, Swerdlow R. New targets for anticancer therapeutics. In: Chabner BA, Longo DL. Cancer chemotherapy and biotherapy: principles and practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2006. p. 549-78. ISBN 978-0-7817-5628-6. TERAPIA ANTICANCER; INIBIDORES DE QUINASES DEPENDENTES DE CICLINA; SB-715992; MEDI-522; VITAXINA; EMD 121974; CILENGITIDE; RAPAMICINA; ALILAMINOGELDANAMICINA; DIMETILAMINOETILAMINO; DEMETOXIGELDANAMICINA |
| 312/399 | US=8 / Quimioterapia Smith MR. Bisphosphonates. In: Chabner BA, Longo DL. Cancer chemotherapy and biotherapy: principles and practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2006. p. 579-86. ISBN 978-0-7817-5628-6. BIFOSFONATOS; FARMACOLOGIA; MECANISMOS DE ACAO; HIPERCALCEMIA; MIELOMA MULTIPLO; CANCER DE MAMA; CANCER DE PROSTATA |
| 313/399 | US=8 / Quimioterapia Richardson P, Mitsiades CS, Hideshima T, Anderson K. Thalidomide and its analogs for the treatment of hematologic malignancies, including multiple myeloma and solid tumors. In: Chabner BA, Longo DL. Cancer chemotherapy and biotherapy: principles and practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2006. p. 587-604. ISBN 978-0-7817-5628-6. TALIDOMIDA; MALIGNIDADES HEMATOLOGICAS; TERAPIA; MIELOMA MULTIPLO; TUMORES SOLIDOS; MECANISMOS DE ACAO; FARMACOLOGIA |
| 314/399 | US=8 / Quimioterapia Zakarija A, Gradishar WJ. Inhibitors of tumor angiogenesis. In: Chabner BA, Longo DL. Cancer chemotherapy and biotherapy: principles and practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2006. p. 605-20. ISBN 978-0-7817-5628-6. INIBIDORES DA ANGIOGENESE TUMORAL; INIBIDORES DE METALOPROTEINASE DE MATRIZ; INIBIDORES DAS CELULAS ENDOTELIAIS |
| 315/399 | US=8 / Quimioterapia O'Connor OA. Proteasome inhibitors. In: Chabner BA, Longo DL. Cancer chemotherapy and biotherapy: principles and practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2006. p. 621-40. ISBN 978-0-7817-5628-6. INIBIDORES DE PROTEASSOMA; QUIMICA; MECANISMOS DE ACAO; FARMACOLOGIA |
| 316/399 | US=8 / Quimioterapia Clark JW. Molecular targeted drugs and growth factor receptor inhibitors. In: Chabner BA, Longo DL. Cancer chemotherapy and biotherapy: principles and practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2006. p. 641-65. ISBN 978-0-7817-5628-6. CANCER. TERAPIA; DROGAS ESPECIFICAS; INIBIDORES DO RECEPTOR DO FATOR DE CRESCIMENTO; ANTICORPOS MONOCLONAIS; IMATINIBA; GEFITINIBA; ERLOTINIBA; OLIGONUCLEOTIDOS ANTI-SENTIDO; TERAPIA GENICA |
| 317/399 | US=8 / Quimioterapia Scheinberg DA, Mulford DA, Jurcic JG, Sgouros G, Junghans RP. Antibody therapies of cancer. In: Chabner BA, Longo DL. Cancer chemotherapy and biotherapy: principles and practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2006. p. 666-98. ISBN 978-0-7817-5628-6. CANCER. TERAPIA; ANTICORPOS; IMUNOGLOBULINA; ONTOGENIA; INTERACAO ANTIGENO-ANTICORPO; FARMACOCINETICA; FARMACODINAMICA; FAGOCITOSE; BLOQUEIO DE RECEPTORES; APOPTOSE; VACINA AB2; RADIOIMUNOTERAPIA; ANTICORPOS MONOCLONAIS; ENSAIOS CLINICOS; RITUXIMABE; ALEMTUZUMABE; HERCEPTINA; BEVACIZUMABE; CETUXIMABE; GEMTUZUMABE OZOGAMICINA |
| 318/399 | US=8 / Quimioterapia Lindner DJ, Taylor KL, Reu FJ, Masci PA, Borden EC. Interferons. In: Chabner BA, Longo DL. Cancer chemotherapy and biotherapy: principles and practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2006. p. 699-717. ISBN 978-0-7817-5628-6. INTERFERON; MECANISMOS DE RESISTENCIA; MECANISMOS ANTITUMORAIS; ANGIOGENESE; FARMACOLOGIA CLINICA |
| 319/399 | US=8 / Quimioterapia June CH. Adoptive cellular therapies. In: Chabner BA, Longo DL. Cancer chemotherapy and biotherapy: principles and practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2006. p. 718-38. ISBN 978-0-7817-5628-6. TERAPIA CELULAR ADOTIVA; IMUNOLOGIA TUMORAL; BIOLOGIA CELULAR; ENSAIOS CLINICOS RANDOMIZADOS; TERAPIA CELULAR GENETICAMENTE MODIFICADA |
| 320/399 | US=8 / Quimioterapia Petros WP. Hematopoietic growth factors. In: Chabner BA, Longo DL. Cancer chemotherapy and biotherapy: principles and practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2006. p. 747-66. ISBN 978-0-7817-5628-6. FATORES DE CRESCIMENTO HEMATOPOIETICOS; QUIMICA; FARMACEUTICA; RECEPTORES DO FATOR DE CRESCIMENTO HEMATOPOIETICO; MECANISMOS DE ACAO; EFEITOS BIOLOGICOS; FARMACOLOGIA CLINICA; DADOS CLINICOS DE MEDICAMENTOS INDIVIDUAIS; ERITROPOIETINA; FATOR ESTIMULANTE DE COLONIAS GRANULOCITOS; FATOR ESTIMULANTE DE COLONIAS MACROFAGOS; INTERLEUCINA 11; TROMBOPOIETINA |